Literature DB >> 8175178

Mechanism of cyclosporine-induced sympathetic activation and acute hypertension in rats.

T Lyson1, D M McMullan, L D Ermel, B J Morgan, R G Victor.   

Abstract

Although intravenous cyclosporine A (CsA) previously has been shown to cause a robust sympathetically mediated increase in blood pressure in the rat, the underlying mechanism by which CsA increases the activity of the sympathetic nervous system is unknown. To determine the relative contributions of central neural versus peripheral reflex mechanisms in causing this sympathetic activation, we recorded efferent renal sympathetic nerve activity and blood pressure during intracerebroventricular or intravenous infusion of CsA, the latter performed in intact rats and in those with sinoaortic denervation, cervical or subdiaphragmatic vagotomy, or dorsal rhizotomy (T10 through L1). In intact rats, intravenous CsA (5 mg/kg), as expected, tripled renal sympathetic nerve activity and increased mean arterial pressure by 27 +/- 4 mm Hg (P < .05). The new findings are that this sympathoexcitatory effect of intravenous CsA (1) was not duplicated by central administration (either into the cerebroventricular system or directly onto the ventrolateral surface of the medulla), (2) was unaffected by sinoaortic denervation, but (3) was greatly attenuated by either cervical or subdiaphragmatic vagotomy or by dorsal rhizotomy. In additional experiments, we found that intravenous cyclosporine increased the multiunit activity of subdiaphragmatic but not cardiopulmonary vagal afferents. From these data, we conclude that in the rat CsA-induced increases in sympathetic activity and blood pressure are caused mainly by activation of excitatory neural reflexes arising in the subdiaphragmatic region. These reflex mechanisms use at least two different afferent neural pathways: one involving the subdiaphragmatic vagi and the other involving the low thoracic dorsal spinal roots.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175178     DOI: 10.1161/01.hyp.23.5.667

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Central modulation of cyclosporine-induced hypertension.

Authors:  Hanan M El-Gowelli; Mahmoud M El-Mas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-29       Impact factor: 3.000

2.  Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings.

Authors:  W Zhang; J L Li; M Hosaka; R Janz; J M Shelton; G M Albright; J A Richardson; T C Südhof; R G Victor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  AKAP150 contributes to enhanced vascular tone by facilitating large-conductance Ca2+-activated K+ channel remodeling in hyperglycemia and diabetes mellitus.

Authors:  Matthew A Nystoriak; Madeline Nieves-Cintrón; Patrick J Nygren; Simon A Hinke; C Blake Nichols; Chao-Yin Chen; Jose L Puglisi; Leighton T Izu; Donald M Bers; Mark L Dell'acqua; John D Scott; Luis F Santana; Manuel F Navedo
Journal:  Circ Res       Date:  2013-12-09       Impact factor: 17.367

4.  Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.

Authors:  S M Gardiner; J E March; P A Kemp; B Fallgren; T Bennett
Journal:  Br J Pharmacol       Date:  2004-01-26       Impact factor: 8.739

5.  Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity.

Authors:  A Lo Russo; A C Passaquin; P André; M Skutella; U T Rüegg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 6.  Learned immunosuppression: extinction, renewal, and the challenge of reconsolidation.

Authors:  Martin Hadamitzky; Harald Engler; Manfred Schedlowski
Journal:  J Neuroimmune Pharmacol       Date:  2012-07-13       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.